In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate

Cancer

Volumn 77, Issue 1, 1996, Pages 144-149

  Janssen, Thierry ^a   Darro, Francis ^b   Petein, Michel ^c   Raviv, Gil ^a,d   Pasteels, Jean Lambert ^b   Kiss, Robert ^b,e,f   Schulman, Claude C ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^d Medical Center of Shiba   (Israel)

^e FNRS   (Belgium)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

androgen; cancer; DU145; LNCaP; PC3; prolactin; proliferation; prostate

Indexed keywords

ANDROGEN; ANDROSTANOLONE; PROLACTIN; TUMOR MARKER;

ANIMAL CELL; ARTICLE; CANCER MODEL; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGENS; CELL DIVISION; HUMANS; KINETICS; MALE; PROLACTIN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030045820     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<144::AID-CNCR24>3.0.CO;2-4     Document Type: Article

References (30)

1. Davies P, Eaton CL. Regulation of prostate growth. J Endocrinol 1991;131:5-17.
2. Serio M, Fiorelli G. Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia. Mol Cell Endocrinol 1991;78: 77-81.
3. Steiner MS. Role of peptide growth factors in the prostate: a review. Urology 1993;99-110.
4. Webber MM. Polypeptide hormones and the prostate. Murphy GP, Sandberg AA, Karr JP, editors. The prostate cell: structure and function. Part B. Prolactin, carcinogenesis and clinical aspects. New York: Alan R. Liss, 1981: 63-88.
5. Farnsworth WE. The normal prostate and its endocrine control, Griffiths K, Pierrepoint CG, editors. Some aspects of aetiology and biochemistry of prostatic cancer. Third Tenovus Workshop. Cardiff: Alpha Omega Alpha, 1970:3-5.
6. MacDonald A, Habib FK. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Int J Cancer 1992;65:177-82.
7. Schuurmans ALG, Bolt I, Veldscholte J, Mulder E. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 1991;40:193-7.
8. Connolly JM, Rose DP. Secretion of epidermal growth factor and related polypeptides by the DU145 human prostate cancer cell line. Prostate 1989;15:177-86.
9. Witorsch RJ. The application of immunoperoxidase methodology for the visualization of prolactin binding sitesin human prostate tissue. Hum Pathol 1979;10: 521-32.
10. Syms AJ, Harper ME, Griffiths K. The effect of prolactin on human BPH epithelial cell proliferation. Prostate 1985;6:145-53.
11. de Launoit Y, Kiss R, Jossa V, Coibion M, Paridaens R, Debacker E, et al. Influences of dihydrotestosterone, testosterone, estradiol, progesterone, or prolactin on the cell kinetics of human hyperplastic prostatic tissue in organ culture. Prostate 1988;13:143-53.
12. Aragona C, Friesen HG. Specific prolactin binding sites in the prostate and testis of rats. Endocrinology 1975;97: 677-84.
13. Kledzik GS, Marshall S, Campbell GA, Gelato M, Meites J. Effects of castration, testosterone, estradiol and prolactin on specific prolactin-binding activity in ventral prostate of male rats. Endocrinology 1976;98:373-9.
14. Purnell DM, Hillman EA, Heatfield BM, Trump RF. Immunoreactive prolactin epithelial cells of normal and cancerous human breast and prostate detected by the unlabeled antibody peroxidase-aantiperoxidase method. Cancer Res 1982;42:2317-24.
15. Costello LC, Franklin RB. Effect of prolactin on the prostate. Prostate 1994;24:162-6.
16. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, et al. LNCaP model of human prostate carcinoma. Cancer Res 1983;43:1809-18.
17. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 1978;21:274-81.
18. Kaighn ME, Narayan S, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC3). Invest Urol 1979;17:16-23.
19. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
20. Janssen T, Kiss R, DeDecker R, Petein M, Pasteels JL, Schulman C. Influence of dihydrotestosterone, epidermal growth factor and basic fibroblast growth factor on the cell kinetics of the PC3, DU145 and LNCaP prostatic cancer cell lines. Relationship with DNA ploidy level. Prostate 1995;27:277-86.
21. Nakamoto T, Chang C, Li A, Chodak GW. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 1992;52:571-7.
22. Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ, Fidler IJ. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992;84:951-7.
23. Pauwels O, Kiss R. Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alleviating and intercalating drugs. Cytometry 1991;12:388-97.
24. Darro F, Camby I, Kruczynski A, Pasteels JL, Martinez J, Kiss R. Characterization of the influence of anti-gastrin, anti-epidermal growth factor, anti-estradiol and anti-luteinizing hormone-releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract. Gut 1995;36:220-30.
25. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, et al. Comparison of in vitro anticancer-drug-screening data generated with tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 1990;82:1113-8.
26. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 1991;51:2515-20.
27. Bhat NR, Hauser KF, Kindy MS. Cell proliferation and protooncogene induction in oligodendroglial progenitors. J Neurosci Res 1992;32:340-9.
28. Darro F, Kruczynski A, Etievant C, Martinez J, Pasteels JL, Kiss R. Characterization of the differentiation of human colorectal cancer cell lines by means of Voronoi diagrams. Cytometry 1993;14:783-92.
29. Kiss R, Salmon I, Camby I, Gras S, Pasteels JL. Characterization of factors in routine laboratory protocols that significantly influence the Feulgen reaction. J Histochem Cytochem 1993;41:935-45.
30. Camby I, Etievant C, Petein M, DeDecker R, van Velthoven R, Danguy A, et al. Influence of culture media on the morphological differentiation of the PC3 and DU145 prostatic neoplastic cell lines. Prostate 1994;24:187-96.